Beckman Coulter = Done Deal

It’s another merger Monday as Danaher (Ticker: DHR) is buying Beckman Coulter (Ticker: BEC) for $83.50 per share in cash. I’ll be generating a total return of 12.13% over a 47 day period. Assuming a holding period of 47 days, the annualized return will be 92.91%, but this is higher since I made a big purchase just last Friday. I’ll probably sell this position sometime this week. I’m keeping a close eye on Emergency Medical Services (Ticker: EMS) and Airgas (Ticker: ARG) as there should be news this week. Genzyme (Ticker: GENZ) is pretty much a done deal as we should hear of a definitive merger agreement from Sanofi (Ticker: SNY) by Wednesday.

Edit:

I sold my Beckman Coulter position at $82.68 on 02/08/11 generating a 11.02% gain.